Presentations

• General presentation on Hib disease and vaccination (July 2008)
• Hib Advocacy Presentation
• Hib Initiative Activities (July 2008)
• Progress of Hib Vaccine Introduction (July 2008)
• Roundtable on child survival: interventions and challenges (May 2007)
• Hib in Africa
• Hib in South and Southeast Asia
• Additional Slides:
• Cost Effectiveness
• Hib Vaccine Financing
• Hib Vaccine Supply and Demand

Slides

• Impact
• Vaccine Utilisation
• Disease Burden and Surveillance
  • Estimates of Mortality
  • Cases and indicators: Africa
  • Cases and indicators: Americas
  • Cases and indicators: Eastern Mediterranean
• Countries with Functional Sentinel Sites
• Other Programmatic Aspects
  • Decision Making
  • Vaccine Products
  • Financing

Impact

	Hib Vaccine Impact CHILE, 1996-2000		Hib Vaccine Impact URUGUAY
	Hib Vaccine Impact EURO		Hib Vaccine Impact USA
	Hib Vaccine Impact THE GAMBIA		Hib Vaccine Impact MALAWI

---

Vaccine Utilisation

	Countries having introduced Hib vaccine in 1997 and 2005		Countries having introduced Hib vaccine and infant Hib coverage, 2005
	Number of countries using different Hib vaccine presentations according to GAVI support – 2005		Global and regional Hib3 coverage in infants, 1990 – 2005
	Global coverage estimates - DTP3 and Hib3, 1980-2005		Number of countries using Hib vaccine in routine infant immunization schedule and proportion of global births in countries using Hib in routine immunization schedule, 1985-2005
	99.4 million infants not immunized (Hib3), 2005

---

Disease Burden and Surveillance

Estimates of Mortality

Hib vaccine impact on meningitis incidence - 2006

Hib pneumonia incidence accounting for vaccine use as of 2006

Cases and indicators: Africa

PBM surveillance performance indicators in AFR 2003 - 2006

Total patients with lab samples, H. influenzae , and S. pneumoniae isolated AFR countries with Hib vaccine introduced 2002-2006*

Cases and indicators: Americas

Hib isolates from invasive diseases in children aged < 6 years - Selected AMR countries - 2000-2004

Cases and indicators: Eastern Mediterranean

PBM surveillance performance indicators in EMR 2004 - 2006

Total patients with lab samples, H. influenzae , and  S. pneumoniae isolated EMR countries with Hib vaccine introduced 2004-2006*

---

Countries with Functional Sentinel Sites

Countries with functional sentinel sites reporting to WHO - 2006

Other Programmatic Aspects

Decision Making

	Status of Hib vaccine introduction by region, 2005		Status of Hib vaccine introduction by country
	Status of Hib vaccine Introduction within GAVI eligible countries, 2005

Vaccine Products

	Hib vaccine presentation used throughout the world - 2005		Hib vaccine products according to number of countries in GAVI and non-GAVI countries, 2005
	Percentage of births in countries using Hib vaccine in routine immunization schedule according to vaccine presentation – 2005

Financing

Source of Hib vaccine financing by country, 2005

Historical weighted average price of pentavalent vaccine offered to GAVI eligible countries